“With the FDA approval of Zeposia, appropriate patients with relapsing forms of multiple sclerosis will have another oral treatment option with meaningful efficacy to help address the disease’s hallmark relapses and brain lesions,” said Samit Hirawat, MD, the company’s chief medical officer.
FDA Approves Zeposia (Ozanimod), Oral Th... - My MSAA Community
FDA Approves Zeposia (Ozanimod), Oral Therapy for All with Relapsing MS
Written by
bxrmom
To view profiles and participate in discussions please or .
3 Replies
•
Thanks for sharing this information! 
Let’s hope it works well!
Not what you're looking for?
You may also like...
Ocrevus: FDA Approves First Drug to Treat Two Forms of MS
includes relapsing-remitting MS (RRMS) as well as secondary-progressive MS (SPMS) with relapses....
First Oral CGRP for Migraine – Ubrelvy – is Approved by FDA
https://migraineagain.com/first-oral-cgrp-for-migraine-ubrelvy-is-approved-by-fda/
Glatopa: FDA Approves Three-Times Weekly Dose
disease-modifying therapy (DMT) approved for the treatment of relapsing forms of multiple sclerosis...
MS relapse indications
(paying more attention to) pre relapse indicators/triggers. I realized my relapses have a...
Blood Test for MS Activity Gets FDA Breakthrough Designation
with relapsing-remitting multiple sclerosis (RRMS) or secondary progressive multiple sclerosis...
Another MSAA News Update - FDA Approves Mavenclad® (Cladribine) Tablets
New Shingles vaccine FDA approved
Possibly another MS therapy
What's Your First Self-Care Remedy During an MS Relapse?
Stopping My MS Therapy
